gamma-aminobutyric acid has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 5 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Joers, JM | 1 |
Deelchand, DK | 1 |
Lyu, T | 1 |
Emir, UE | 1 |
Hutter, D | 1 |
Gomez, CM | 1 |
Bushara, KO | 1 |
Eberly, LE | 1 |
Öz, G | 1 |
Nakamura, K | 1 |
Yoshida, K | 1 |
Miyazaki, D | 1 |
Morita, H | 1 |
Ikeda, S | 1 |
Sultan, F | 1 |
König, T | 1 |
Möck, M | 1 |
Thier, P | 1 |
Gazulla, J | 2 |
Tintoré, MA | 1 |
Tintoré, M | 1 |
1 review available for gamma-aminobutyric acid and Autosomal Dominant Cerebellar Ataxia, Type II
Article | Year |
---|---|
The P/Q-type voltage-dependent calcium channel: a therapeutic target in spinocerebellar ataxia type 6.
Topics: Amines; Anticonvulsants; Calcium; Calcium Channel Blockers; Calcium Channels, N-Type; Cyclohexanecar | 2007 |
1 trial available for gamma-aminobutyric acid and Autosomal Dominant Cerebellar Ataxia, Type II
Article | Year |
---|---|
Spinocerebellar ataxia type 6 (SCA6): clinical pilot trial with gabapentin.
Topics: Adult; Aged; Amines; Brain; Calcium Channel Blockers; Cyclohexanecarboxylic Acids; Female; Gabapenti | 2009 |
3 other studies available for gamma-aminobutyric acid and Autosomal Dominant Cerebellar Ataxia, Type II
Article | Year |
---|---|
Neurochemical abnormalities in premanifest and early spinocerebellar ataxias.
Topics: Activities of Daily Living; Adult; Aged; Aspartic Acid; Ataxins; Brain; Brain Diseases, Metabolic; C | 2018 |
Quantitative organization of neurotransmitters in the deep cerebellar nuclei of the Lurcher mutant.
Topics: Animals; Cell Count; Cerebellar Nuclei; gamma-Aminobutyric Acid; Glutamic Acid; Glycine; Immunohisto | 2002 |
The P/Q-type voltage-dependent calcium channel as pharmacological target in spinocerebellar ataxia type 6: gabapentin and pregabalin may be of therapeutic benefit.
Topics: Amines; Calcium Channel Blockers; Calcium Channels, P-Type; Calcium Channels, Q-Type; Cyclohexanecar | 2007 |